Saturday, February 24, 2018
health & safety event – home – mar 2018

Latest news

BenevolentAI to hasten AI-enabled drug development with new facility

BenevolentAI to hasten AI-enabled drug development with new facility

BenevolentAI has acquired a state-of-the-art drug discovery and development facility on the Babraham Research Campus in Cambridge, UK for an undisclosed sum. The acquisition creates...
Precision drug could treat different cancers with rare gene fault

Precision drug could treat different cancers with rare gene fault

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body. Three quarters...
Manufacturing collaboration for WuXi STA and Regulus

Manufacturing collaboration for WuXi STA and Regulus

STA Pharmaceutical, a WuXi AppTec group company, and biopharma Regulus Therapeutics have entered into an oligonucleotide synthesis collaboration agreement for research and mid-scale non-GMP/cGMP...